Curaleaf Holdings (CURLF) Non-Current Debt (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Non-Current Debt of $512.9 million for Q4 2025, up 9.86% year-over-year from $466.9 million in Q4 2024, and up 9.86% quarter-over-quarter from $466.9 million in Q4 2024.
Curaleaf Holdings (CURLF) Non-Current Debt (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Non-Current Debt history runs 7 years deep, the most recent figure standing at $512.9 million for Q4 2025.
- In Q4 2025, Non-Current Debt rose 9.86% year-over-year to $512.9 million; the TTM figure through Dec 2025 stood at $512.9 million (up 9.86% YoY), while the FY2025 annual figure was $512.9 million, up 9.86% from the prior year.
- Non-Current Debt for Q4 2025 stood at $512.9 million, up from $466.9 million in the prior quarter.
- The five-year high for Non-Current Debt was $582.0 billion in Q1 2022, with the low at $335.3 million in Q1 2021.
- The 5-year median for Non-Current Debt is $489.9 million (2024), against an average of $42.0 billion.
- The sharpest annual moves came in 2022 and 2024: Non-Current Debt jumped 173458.09% in 2022, then retreated 14.84% in 2024.
- Curaleaf Holdings' Non-Current Debt stood at $457.9 million in 2021, then jumped by 30.41% to $597.2 million in 2022, then fell by 8.19% to $548.3 million in 2023, then declined by 14.84% to $466.9 million in 2024, then increased by 9.86% to $512.9 million in 2025.
- Business Quant data shows CURLF's Non-Current Debt at $512.9 million in Q4 2025, $466.9 million in Q4 2024, and $461.5 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 130.00 Mn |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | 570.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 570.53 Mn |
| Dec 31, 2025 | 512.92 Mn |
| Dec 31, 2024 | 466.90 Mn |
| Sep 30, 2024 | 461.48 Mn |
| Jun 30, 2024 | 460.32 Mn |
| Dec 31, 2023 | 548.29 Mn |
| Sep 30, 2023 | 522.38 Mn |
| Jun 30, 2023 | 525.60 Mn |
| Sep 30, 2022 | 597.18 Mn |
| Jun 30, 2022 | 584.95 Mn |
| Mar 31, 2022 | 581.98 Bn |
| Dec 31, 2021 | 457.92 Mn |
| Sep 30, 2021 | 340.25 Mn |
| Jun 30, 2021 | 336.45 Mn |
| Mar 31, 2021 | 335.32 Mn |
| Dec 31, 2020 | 285.00 Mn |
| Sep 30, 2020 | 273.70 Mn |
| Dec 31, 2019 | 87.95 Mn |